Complete remission of hepatitis b virus-associated nephrotic syndrome from IgA nephropathy following peginterferon therapy

Renal Failure

Volumn 35, Issue 2, 2013, Pages 295-298

  Shah, Hitesh H ^a   Patel, Chinmay ^a   Jhaveri, Kenar D ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Glomerulonephritis; Hepatitis B virus infection; IgA nephropathy; Nephropathy; Peginterferon therapy

Indexed keywords

ATORVASTATIN; FUROSEMIDE; METOLAZONE; PEGINTERFERON ALPHA2B; RAMIPRIL;

ADULT; ANASARCA; ARTICLE; CASE REPORT; GLOMERULOPATHY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; INFORMATION; KIDNEY BIOPSY; LIVER BIOPSY; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; REMISSION; VIRUS LOAD; WEIGHT GAIN;

ANTIVIRAL AGENTS; BIOPSY, NEEDLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-ALPHA; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84873628741     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.745785     Document Type: Article

References (19)

1. Combes B, Shorey J, Barrera A, et al. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet. 1971;2(7718):234-237.
2. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol. 2004;24(2):198-211.
3. Khedmat H, Taheri S. Hepatitis B virus-associated nephropathy: an International Data Analysis. Iran J Kidney Dis. 2010;4(2):101-105.
4. Panomsak S,LewsuwanS,Eiam-OngS,KanjanabuchT.Hepatitis-B virus-associated nephropathies in adults: a clinical study in Thailand. JMed Assoc Thai. 2006;89(Suppl. 2):S151-S156.
5. Lai KN, Lai FM. Clinical features and the natural course of hepatitis B virus-related glomerulopathy in adults. Kidney Int Suppl. 1991;35:S40-S45.
6. Elewa U, Sandri AM, Kim WR, Fervenza FC. Treatment of hepatitis B virus-associated nephropathy. Nephron Clin Pract. 2011;119(1):c41-c49.
7. Zhang Y, Zhou JH, Yin XL, Wang FY. Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol. 2010;16(6):770-777.
8. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97-107.
9. Southwest Pediatric Nephrology Study Group. Hepatitis B surface antigenemia in North American children with membranous glomerulonephropathy. J Pediatr. 1985;106(4):571-578.
10. Wang NS, Wu ZL, Zhang YE, Liao LT. Existence and significance of hepatitis B virus DNA in kidneys of IgA nephropathy. World J Gastroenterol. 2005;11(5):712-716.
11. MaX, ZhangY,DuW.The relationship between IgAnephropathy andHBV infection. Zhonghua Yi Xue Za Zhi. 1999;79(6):417-421.
12. Lai KN, Lai FM, Tam JS. IgA nephropathy associated with chronic hepatitis B virus infection in adults: the pathogenetic role of HBsAG. J Pathol. 1989;157(4):321-327.
13. Lai KN, Lai FM, Tam JS, Vallance-Owen J. Strong association between IgA nephropathy and hepatitis B surface antigenemia in endemic areas. Clin Nephrol. 1988;29(5):229-234.
14. Ohba S, Kimura K, Mise N, et al. Differential localization of s and e antigens in hepatitis B virus-associated glomerulonephritis. Clin Nephrol. 1997;48(1):44-47.
15. Lai KN, Tam JS, Lin HJ, Lai FM. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron. 1990;54(1):12-17.
16. Zheng XY, Wei RB, Tang L, Li P, Zheng XD. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis. World J Gastroenterol. 2012;18(8):821-832.
17. Fabrizi F, Dixit V, Martin P. Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis. Aliment Pharmacol Ther. 2006;24(5):781-788.
18. Ozdamar SO, Gucer S, Tinaztepe K. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children. Pediatr Nephrol. 2003;18(1):23-28.
19. Marcellin P, Lau GK, Bonino F, et al. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. N Engl J Med. 2004;351(12):1206-1217.